Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial

Aaron R. Weiss, Yen‐Lin Chen, Thomas J. Scharschmidt, Yueh-Yun Chi, Jing Tian, Jennifer O. Black, Jessica L. Davis, Julie C. Fanburg–Smith, Eduardo Zambrano, James R. Anderson, Robin Arens, Odion Binitie, Edwin Choy, J. Wade Davis, Andrea Hayes‐Jordan, Simon C. Kao, Mark L. Kayton, Sandy Kessel, Ruth Lim, William H. Meyer, Lynn Million, Scott H. Okuno, Andrew Ostrenga, Marguerite T. Parisi, Daniel A. Pryma, R. Lor Randall, Mark Rosen, Mary Schlapkohl, Barry L. Shulkin, Ethan A. Smith, Joel Sorger, Stephanie Terezakis, Douglas S. Hawkins, Sheri L. Spunt, Dian Wang